ArticleJAMA network open2026
Implementation Readiness for National Cancer Survivorship Care Standards.
Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Cancer survivorship care is a growing public health priority, yet delivery remains variable across health systems. The National Standards for Cancer Survivorship Care provide a framework for high-quality care, but little empirical evidence exists regarding health system readiness to implement these standards in routine practice. Objective: To assess implementation readiness for the National Standards for Cancer Survivorship Care and identify perceived barriers to implementation. Design, Setting, and Participants: This real-time Delphi survey study was conducted from January to March 2025 at a National Cancer Institute-designated comprehensive cancer center. Participants were multidisciplinary experts involved in cancer survivorship care delivery, care coordination, and program implementation. Main Outcomes and Measures: For each of the 10 survivorship standards, expert agreement was assessed across 6 implementation domains: importance, anticipated impact, feasibility, consistency of implementation and documentation, existence of formal organizational policies, and presence of health system evaluation mechanisms. Agreement was considered present when at least 50% of respondents selected a single response category. Results: Of 30 experts recruited, 25 participated (19 [76%] female), for a response rate of 83%. Among the 10 standards, agreement was consistently achieved for importance (9 standards [90%]) and anticipated impact (all 10 standards). In contrast, agreement regarding the existence of formal organizational policies and health system evaluation mechanisms was limited, and respondents frequently indicated absence or uncertainty. Agreement on implementation consistency was also limited, with several standards reaching agreement that implementation was inconsistent across practitioners and settings. Standards requiring coordination across clinicians, care settings, and supportive services were generally perceived as less ready for implementation than those supported by more established workflows. Qualitative findings identified cross-cutting barriers including time constraints, workforce limitations, lack of standardized workflows, and electronic health record limitations. Conclusions and Relevance: Experts endorsed the cancer survivorship standards as important and potentially high impact but identified substantial gaps in the organizational infrastructure needed for consistent implementation. These findings suggest that improving survivorship care will require investments in workflows, accountability structures, and evaluation systems that support routine delivery and measurement of survivorship care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.